REFERENCES
[1] Nilsson, L., Brockow, K., Alm, J., Cardona, V., Caubet, J. C.,
Gomes, E., … & Zanoni, G. (2017). Vaccination and allergy: EAACI
position paper, practical aspects. Pediatric Allergy and
Immunology, 28(7), 628-640.
[2] Institute of Medicine (US). Committee to Review Adverse Effects
of Vaccines, Stratton, K. R., & Clayton, E. W. (2012). Adverse effects
of vaccines: evidence and causality.
[3] Micheletti, F., Peroni, D., Piacentini, G., Schweiger, V.,
Mirandola, R., Chiesa, E., & Zanoni, G. (2012). Vaccine allergy
evaluation and management at the specialized Green Channel Consultation
Clinic. Clinical & Experimental Allergy, 42(7), 1088-1096.
[4] Su, J. R., Moro, P. L., Ng, C. S., Lewis, P. W., Said, M. A., &
Cano, M. V. (2019). Anaphylaxis after vaccination reported to the
vaccine adverse event reporting system, 1990-2016. Journal of Allergy
and Clinical Immunology, 143(4), 1465-1473.
[5] McNeil, M. M., Weintraub, E. S., Duffy, J., Sukumaran, L.,
Jacobsen, S. J., Klein, N. P., … & DeStefano, F. (2016). Risk of
anaphylaxis after vaccination in children and adults. Journal of Allergy
and Clinical Immunology, 137(3), 868-878.
[6] Gold, M., Goodwin, H., Botham, S., Burgess, M., Nash, M., &
Kempe, A. (2000). Re-vaccination of 421 children with a past history of
an adverse vaccine reaction in a special immunisation service. Archives
of disease in childhood, 83(2), 128-131.
[7] Wood, R. A. (2013). Allergic reactions to vaccines. Pediatric
Allergy and Immunology, 24(6), 521-526.
[8] Kimberlin, D. W., Brady, M. T., Jackson, M. A., Long, S. S., &
American Academy of Pediatrics. (2015). Red book: 2015 report of the
Committee on Infectious Diseases. American academy of pediatrics, 432,
445.
[9] Halsey, N. A., Griffioen, M., Dreskin, S. C., Dekker, C. L.,
Wood, R., Sharma, D., … & Kelso, J. M. (2013). Immediate
hypersensitivity reactions following monovalent 2009 pandemic influenza
A (H1N1) vaccines: reports to VAERS. Vaccine, 31(51), 6107-6112.
[10] Franceschini, F., Bottau, P., Caimmi, S., Cardinale, F.,
Crisafulli, G., Liotti, L., … & Caffarelli, C. (2018, May).
Evaluating children with suspected allergic reactions to vaccines for
infectious diseases. In Allergy & Asthma Proceedings (Vol. 39, No. 3).
[11] Muraro, A., Worm, M., Alviani, C., Cardona, V., DunnGalvin, A.,
Garvey, L. H., … & European Academy of Allergy and Clinical
Immunology, Food Allergy, Anaphylaxis Guidelines Group. (2022). EAACI
guidelines: Anaphylaxis (2021 update). Allergy, 77(2), 357-377.
[12] Gold, M. S., Amarasinghe, A., Greenhawt, M., Kelso, J. M.,
Kochhar, S., Thong, B. Y. H., … & Law, B. (2022). Anaphylaxis:
Revision of the Brighton collaboration case definition. Vaccine.
[13] Arcolaci, A., Bronte, V., & Zanoni, G. (2021). Immunization
practices and risk of anaphylaxis: a current update, comprehensive of
COVID-19 vaccination data. Current Opinion in Allergy and Clinical
Immunology, 21(5), 418-425.
[14] Miller ER, McNeil MM, Moro, et al. The reporting sensitivity of
the Vaccine Adverse Event Reporting System (VAERS) for anaphylaxis and
for GuillainBarre syndrome. Vaccine 2020; 38:7458–7463
[15] Bohlke, K., Davis, R. L., Marcy, S. M., Braun, M. M.,
DeStefano, F., Black, S. B., … & Vaccine Safety Datalink Team.
(2003). Risk of anaphylaxis after vaccination of children and
adolescents. Pediatrics, 112(4), 815-820.
[16] Castells MC, Phillips EJ. Maintaining Safety with SARS-CoV-2
Vaccines. N Engl J Med. 2021;384(7):643-649.
[17] Caubet, J. C., & Ponvert, C. (2014). Vaccine
allergy. Immunology and Allergy Clinics, 34(3), 597-613.
[18] Echeverría-Zudaire, L. A., Ortigosa-del Castillo, L.,
Alonso-Lebrero, E., Álvarez-García, F. J., Cortés-Álvarez, N.,
García-Sánchez, N., & Martorell-Aragonés, A. (2015). Consensus document
on the approach to children with allergic reactions after vaccination or
allergy to vaccine components. Allergologia et Immunopathologia, 43(3),
304-325.
[19] Aytekin, E. S., Şekerel, B. E., & Şahiner, Ü. M. (2021).
Allergic reactions during childhood vaccination and management. The
Turkish Journal of Pediatrics, 63(6), 941-954.
[20] Sarti L, Lezmi G, Mori F, Giovannini M, Caubet JC. Diagnosis
and management of hypersensitivity reactions to vaccines. Expert Rev
Clin Immunol. 2020 Sep;16(9):883-896. doi:
10.1080/1744666X.2020.1814745. Epub 2020 Sep 29. PMID: 32838592.
[21] Zanoni, G., Migliorini, M., Gallo, T., Guidolin, L., & Schena,
D. (2020). Recurrent injection site reactions to vaccines: two clinical
patterns of presentation. Vaccine, 38(45), 6985-6989.
[22] Bergfors E, Inerot A, Falk L, Nyström U, Trollfors B. Patch
testing children with aluminium chloride hexahydrate in petrolatum: A
review and a recommendation. Contact Dermatitis. 2019 Aug;81(2):81-88.
doi: 10.1111/cod.13303. Epub 2019 May 31. PMID: 31066081
[23] Bergfors E, Trollfors B. Sixty-four children with persistent
itching nodules and contact allergy to aluminium after vaccination with
aluminium-adsorbed vaccines-prognosis and outcome after booster
vaccination. Eur J Pediatr. 2013 Feb;172(2):171-7. doi:
10.1007/s00431-012-1841-2. Epub 2012 Oct 11. PMID: 23052615.
[24] Caubet, J. C., Rudzeviciene, O., Gomes, E., Terreehorst, I.,
Brockow, K., & Eigenmann, P. A. (2014). Managing a child with possible
allergy to vaccine. Pediatric Allergy and Immunology, 25(4), 394-403.
[25] https://www.hopkinsvaccine.org/cc-mmr.html
[26] Kelso JM, Greenhawt MJ, Li JT, et al. Adverse reactions to
vaccines practice parameter 2012 update. J Allergy Clin Immunol
2012;130: 25-43
[27] Wood RA, Setse R, Halsey N. Clinical Immunization Safety
Assessment (CISA) Network Hypersensitivity Working Group. Irritant skin
test reactions to common vaccines. J Allergy Clin Immunol. 2007; 120:
478- 481.
[28] Lopez-Serrano, M. C., Caballero, M. T., Barranco, P., &
Martinez-Alzamora, F. (1996). Booster responses in the study of allergic
reactions to beta-lactam antibiotics. Journal of investigational
allergology & clinical immunology, 6(1), 30-35.
[29] Wood, R. A., Berger, M., Dreskin, S. C., Setse, R., Engler, R.
J., Dekker, C. L., … & Hypersensitivity Working Group of the Clinical
Immunization Safety Assessment (CISA) Network. (2008). An algorithm for
treatment of patients with hypersensitivity reactions after vaccines.
Pediatrics, 122(3), e771-e777.
[30] Miyazawa, H., Inouye, S., & Sakaguchi, M. (2000).
Sensitization to gelatin in children with systemic non-immediate-type
reactions to varicella vaccines. Annals of Allergy, Asthma &
Immunology, 84(3), 341-344.
[31] Des Roches, A., Paradis, L., Gagnon, R., Lemire, C., Bégin, P.,
Carr, S., … & De Serres, G. (2012). Egg-allergic patients can be
safely vaccinated against influenza. Journal of Allergy and Clinical
Immunology, 130(5), 1213-1216.
[32] Turner, P. J., Southern, J., Andrews, N. J., Miller, E.,
Erlewyn-Lajeunesse, M., Doyle, C., … & Thomas, H. M. (2015). Safety
of live attenuated influenza vaccine in atopic children with egg
allergy. Journal of Allergy and Clinical Immunology, 136(2), 376-381.
[33] Des Roches, A., Samaan, K., Graham, F., Lacombe-Barrios, J.,
Paradis, J., Paradis, L., & De Serres, G. (2015). Safe vaccination of
patients with egg allergy by using live attenuated influenza vaccine.
The Journal of Allergy and Clinical Immunology: In Practice, 3(1),
138-139.
[34] Grohskopf, L. A., Alyanak, E., Broder, K. R., Walter, E. B.,
Fry, A. M., & Jernigan, D. B. (2019). Prevention and control of
seasonal influenza with vaccines: recommendations of the Advisory
Committee on Immunization Practices—United States, 2019–20 influenza
season. MMWR Recommendations and reports, 68(3), 1.
[35] World Health Organization. (2013). Rotavirus vaccines: WHO
position paper—January 2013. Weekly Epidemiological Record= Relevé
épidémiologique hebdomadaire, 88(05), 49-64.
[36] Jackson, L. A., Carste, B. A., Malais, D., & Froeschle, J.
(2002). Retrospective population-based assessment of medically attended
injection site reactions, seizures, allergic responses and febrile
episodes after acellular pertussis vaccine combined with diphtheria and
tetanus toxoids. The Pediatric infectious disease journal, 21(8),
781-786.
[37] Cheng, D. R., Perrett, K. P., Choo, S., Danchin, M., Buttery,
J. P., & Crawford, N. W. (2015). Pediatric anaphylactic adverse events
following immunization in Victoria, Australia from 2007 to 2013.
Vaccine, 33(13), 1602-1607.
[38] Beveridge, M. G., Polcari, I. C., Burns, J. L., Adler, A.,
Hendrickson, B., & Stein, S. L. (2012). Local vaccine site reactions
and contact allergy to aluminum. Pediatric dermatology, 29(1), 68-72.
[39] Kattan, J. D., Konstantinou, G. N., Cox, A. L., Nowak-Węgrzyn,
A., Gimenez, G., Sampson, H. A., & Sicherer, S. H. (2011). Anaphylaxis
to diphtheria, tetanus, and pertussis vaccines among children with cow’s
milk allergy. Journal of allergy and clinical immunology, 128(1),
215-218.
[40] DiMiceli, L., Pool, V., Kelso, J. M., Shadomy, S. V., Iskander,
J., & VAERS Team. (2006). Vaccination of yeast sensitive individuals:
review of safety data in the US vaccine adverse event reporting system
(VAERS). Vaccine, 24(6), 703-707.
[41] Parisi, C. A. S., Smaldini, P. L., Gervasoni, M. E., Maspero,
J. F., & Docena, G. H. (2013). Hypersensitivity reactions to the Sabin
vaccine in children with cow’s milk allergy. Clinical & Experimental
Allergy, 43(2), 249-254.
[42] Arroabarren, E., Anda, M., & Sanz, M. L. (2016). Anaphylaxis
to pneumococcal vaccine; CRM (197): novel cause of vaccine allergy.
Pediatric Allergy and Immunology, 27(4), 433-437.
[43] Myers, T. R., McNeil, M. M., Ng, C. S., Li, R., Lewis, P. W.,
& Cano, M. V. (2017). Adverse events following quadrivalent
meningococcal CRM-conjugate vaccine (Menveo®) reported to the Vaccine
Adverse Event Reporting system (VAERS), 2010–2015. Vaccine, 35(14),
1758-1763.
[44] Perez-Vilar, S., Dores, G. M., Marquez, P. L., Ng, C. S., Cano,
M. V., Rastogi, A., … & Duffy, J. (2022). Safety surveillance of
meningococcal group B vaccine (Bexsero®), Vaccine Adverse Event
Reporting System, 2015–2018. Vaccine, 40(2), 247-254.
[45] Markowitz, L. E., Dunne, E. F., Saraiya, M., Chesson, H. W.,
Curtis, C. R., Gee, J., … & Unger, E. R. (2014). Human papillomavirus
vaccination: recommendations of the Advisory Committee on Immunization
Practices (ACIP). Morbidity and Mortality Weekly Report: Recommendations
and Reports, 63(5), 1-30.
[46] Badiu, I., Geuna, M., Heffler, E., & Rolla, G. (2012).
Hypersensitivity reaction to human papillomavirus vaccine due to
polysorbate 80. Case Reports, 2012, bcr0220125797.
[47] Greenhawt, M., Abrams, E. M., Shaker, M., Chu, D. K., Khan, D.,
Akin, C., … & Golden, D. B. (2021). The risk of allergic reaction to
SARS-CoV-2 vaccines and recommended evaluation and management: a
systematic review, meta-analysis, GRADE assessment, and international
consensus approach. The Journal of Allergy and Clinical Immunology: In
Practice, 9(10), 3546-3567.
[48] Greenhawt M, Abrams EM, Oppenheimer J, Vander Leek TK, Mack DP,
Singer AG, et al. The COVID-19 pandemic in 2021: avoiding overdiagnosis
of anaphylaxis risk while safely vaccinating the world. J Allergy Clin
Immunol Pract 2021;9:1438-41.
[49] Banerji A, Wickner PG, Saff R, Stone CA Jr, Robinson LB, Long
AA, et al. mRNA vaccines to prevent COVID-19 disease and reported
allergic reactions: current evidence and suggested approach. J Allergy
Clin Immunol Pract 2021;9:1423-37.
[50] Greenhawt, M., Shaker, M., & Golden, D. B. (2021).
PEG/polysorbate skin testing has no utility in the assessment of
suspected allergic reactions to SARS-CoV-2 vaccines. The Journal of
Allergy and Clinical Immunology: In Practice, 9(9), 3321-3322.
[51] American Academy of Pediatrics. Active and passive
immunization. In: Pickering LK, editor. Red Book: 2009 Report of the
Committee on Infectious Diseases. 28th edn Elk Grove Village, IL:
American Academy of Pediatrics; 2009. p. 48.
[52] Kelso JM. Update on vaccination guidelines for allergic
children. Expert Rev Vaccines. 2009;8:1541—6.
[53] Zent O, Arras-Reiter C, Broeker M, Hennig R. Immediate allergic
reactions after vaccinations — a post-marketing surveillance
review. Eur J Pediatr. 2002;161:21—5.
[54] Eggesbo M, Botten G, Halvorsen R, Magnus P. The prevalence of
allergy to egg: a population-based study in young children. Allergy.
2001;56:403—11.
[55] Zanoni, G., Puccetti, A., Dolcino, M., Simone, R., Peretti, A.,
Ferro, A., & Tridente, G. (2008). Dextran-specific IgG response in
hypersensitivity reactions to measles-mumps-rubella vaccine. Journal of
Allergy and Clinical Immunology, 122(6), 1233-1235.
[56] Zanoni, G., Zanotti, R., Schena, D., Sabbadini, C., Opri, R.,
& Bonadonna, P. (2017). Vaccination management in children and adults
with mastocytosis. Clinical & Experimental Allergy, 47(4), 593-596.
[57] Gallo, G., Mel, R., Ros, E., & Filia, A. (2019). Guide to
contraindications to vaccination (2018 update). Rapporti
ISTISAN-Istituto Superiore di Sanità, (19/3).
Figure 1: Algorithm to select and manage vaccination of
patients who refer a previous suggestive allergic reaction to a vaccine.